Pancreatic Cancer Research

ResearcherGyeongsang National UniversityNo recent work listed

Se‐Il Go

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-3025-6096; OpenAlex author ID A5108693236. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2012: 1 paper · 2013: none · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: 1 paper

Papers 2

  1. Modified FOLFIRINOX versus S-1 as second-line chemotherapy in gemcitabine-failed metastatic pancreatic cancer patients: A randomised controlled trial (MPACA-3). Co-author DOI 10.1016/j.ejca.2021.08.002↗
  2. A phase II trial of Erlotinib in combination with gemcitabine and cisplatin in advanced pancreatic cancer. Co-author DOI 10.1007/s10637-012-9792-z↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jung Hun Kang · 2 shared papers, 2012–2021 · strength 0.14
  2. In Gyu Hwang · 2 shared papers, 2012–2021 · strength 0.14
  3. Jung Hoon Kim · 1 shared paper, 2021 · strength 0.11
  4. Dae Young Zang · 1 shared paper, 2021 · strength 0.11
  5. Woo Kyun Bae · 1 shared paper, 2021 · strength 0.11
  6. Jun Ho Ji · 1 shared paper, 2021 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.